Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,AIKN CDI May Update

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI) has
    recently been updated with new content including presentation slides from EBMT and
    ECCMID 2015, a gut microflora animation unveiled at the Astellas stand during
    ECCMID 2015, recent articles added to the ‘CDI perspectives’ section and the
    opportunity to participate in a second round consensus questionnaire for the
    ​largest ever clinician consensus report.

    May 2015 MYC/15/0020/EUb

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

  • ,Whats new Psoriasis Knowledge centre

    Launch of Psoriasis Knowledge Centre

    A new Psoriasis Knowledge Centre has launched on epgonline.org
    to provide dermatologists, family medicine physicians and other healthcare
    professionals with free access to relevant information on psoriasis including
    pathophysiology, comorbidities, signs and symptoms, diagnosis and more.

  • ,What's New ECCMID IFI

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    The AIKN-IFI has been updated with four presentations from the Astellas-sponsored
    symposium at the 25th European Congress of Clinical Microbiology and Infectious
    Diseases (ECCMID) 2015
    . The congress took place on 25–28 April in Copenhagen,
    Denmark. Visit the congresses section of this resource to view and download the slides
    free of charge.

    May 2015 MYC/15/0040/EUb

  • ,Whats's New Diabetes Knowledge Centre Relaunch

    Updated Type 2 Diabetes Mellitus Knowledge Centre

    Explore new information added to the diagnosis and treatment sections of the
    Type 2 Diabetes Mellitus Knowledge Centre with recommendations on the appropriate
    management of the condition. A brand new guidelines section is also available,
    containing the latest recommendations from ADA, EASD and NICE.

Latest News

Gevokizumab fails Phase III trial for Behçet's uveitis- XOMA + Servier


XOMA Corporation announced the Phase III EYEGUARD-B study of gevokizumab in patients with Behçet's disease uveitis, run by its partner Servier did not meet the primary endpoint of time to first acute ocular exacerbation. "Although the study did not ...

AstraZeneca initiates Phase IIa study of AZD 9412 (inhaled interferon beta) for severe asthma


AstraZeneca has commenced its Phase IIa study of AZD 9412 (inhaled interferon beta, developed by Synairgen and formerly known as SNG 001). The study population will comprise patients with severe asthma, building on the clinical data from ...

Kyprolis (carfilzomib) filed with FDA for expanded indication in multiple myeloma- Amgen


Amgen announced the submission of a supplemental New Drug Application (sNDA) to the FDA for Kyprolis (carfilzomib) to seek an expanded indication for the treatment of patients with relapsed multiple myeloma, who have received at least one prior ...

New phase IV results show significant improvement with Nuedexta (dextromethorphan and quinidine sulphate) in pseudobulbar affect- Avanir Pharma


Avanir Pharmaceuticals announced new findings from the dementia/Alzheimer's disease cohort of the PRISM II study, a Phase IV study evaluating the safety and effectiveness of Nuedexta (dextromethorphan and quinidine sulphate) in treating ...

NICE recommends Moventig (naloxegol) for treatment of opioid-induced constipation- AstraZeneca


The National Institute for Health and Care Excellence (NICE) in new final guidelines has recommended Moventig (naloxegol) from AstraZeneca as a cost-effective option for treating opioid-induced constipation in adults whose symptoms have not ...

Grazoprevir/elbasvir single tablet combo filed in EU for Hepititis C genotypes 1, 3, 4 or 6 - Merck Inc


Merck Inc announced the European Medicines Agency has accepted for review a marketing authorization application for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult ...

Roche revives development of gantenerumab in Phase III trial for mild Alzheimer's-related dementia


Roche is to revive the development of gantenerumab after it had failed to improve cognition or function compared to placebo in the now discontinued SCARLET ROAD trial for Alzheimer's disease. This drug is directed at beta amyloid toxic plaques ...

Recent Updates


Clinical Guidelines

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Suspected cancer: recognition and referral

Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index

Medical Journals

Tiotropium and salmeterol in COPD patients at risk of exacerbations: a post hoc analysis from POET-COPD.

Functional Impairments Mediate Association Between Clinical Fracture Risk and Type 2 Diabetes Mellitus in Older Women.

Treating patients with metastatic castration-resistant prostate cancer: a comprehensive review of available therapies.

The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors